Global Brain Cancer Diagnostics Market

Global brain cancer diagnostics market by test type (imaging test (MRI, CT, PET), lumbar puncture, biopsy, molecular testing, others), by cancer type (glioblastoma multiforme, astrocytomas, ependymomas, others), by end user (hospitals & clinics, ambulatory surgical centers (ASCs), others), by region (Asia Pacific, Europe, North America, Rest of the World (RoW)), outlook & forecast, 2021-2027

SKU: MGH01473 Category: Region:

USD2,400.00

Description

Brain cancer is a disease of the brain in which cancer cells (malignant cells) arise in the brain tissue (cancer of the brain). Brain cancer can have a wide variety of symptoms including seizures, sleepiness, confusion, and behavioral changes. According to latest analysis by Gen Consulting Company, the global brain cancer diagnostics market was USD 1,078 million in 2020 and is expected to reach USD 2,168 million in 2027 and register a CAGR of 10.5% during the forecast period, 2021-2027.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global brain cancer diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the brain cancer diagnostics industry.

The brain cancer diagnostics market is segmented on the basis of test type, cancer type, end user, and region. The brain cancer diagnostics market is segmented as below:

By test type:
– imaging test (MRI, CT, PET)
– lumbar puncture
– biopsy
– molecular testing
– others

By cancer type:
– glioblastoma multiforme
– astrocytomas
– ependymomas
– others

By end user:
– hospitals & clinics
– ambulatory surgical centers (ASCs)
– others

By region:
– region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Brain Cancer Diagnostics Market, including Biocept, Inc., Canon Medical Systems Corporation, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., NantOmics, LLC, Neusoft Medical Systems Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global brain cancer diagnostics market.
– To classify and forecast the global brain cancer diagnostics market based on test type, cancer type, end user, and region.
– To identify drivers and challenges for the global brain cancer diagnostics market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global brain cancer diagnostics market.
– To identify and analyze the profile of leading players operating in the global brain cancer diagnostics market.

Why Choose This Report
– Gain a reliable outlook of the global brain cancer diagnostics market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Interested in this report? Get your FREE sample now!
Global Brain Cancer Diagnostics Market

Please fill out our form and we will get back to you.